Throat News and Research

RSS

Blunted antiviral responses in the nasopharynx may underlie severe COVID-19

The body's first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx. A new study in the journal Cell suggests that the first responses in this battleground help determine who will develop severe disease and who will get through with mild or no illness.

23 Jul 2021

Virginia Tech's in-house development of novel SARS-CoV-2 test shows the power of academic labs

In the early days of the pandemic, scientists at Virginia Tech created a COVID-19 testing laboratory and novel test for the virus from scratch.

21 Jul 2021

Human coronaviruses need organic materials to transfer efficiently between surfaces

This study, published in the journal Viruses, indicated that human coronaviruses do not transfer effectively from contaminated hands to contact surfaces without the presence of any organic material.

21 Jul 2021

Study finds dramatic decreases in antibiotic dispensing for children during the pandemic

As children made fewer visits to health facilities and engaged in social distancing and other COVID-19 mitigation measures, a smaller number of them also received prescription drugs, a new study suggests.

20 Jul 2021

Patient's case report reveals link between Bell’s palsy and Pfizer-BioNTech vaccine

The case of a patient who experienced two facial palsies – one after the first and another after the second dose of the Pfizer-BioNTech COVID-19 vaccine – strongly suggests that Bell’s palsy (facial nerve palsy of unknown cause) is linked to the Pfizer-BioNTech vaccine, doctors write in the journal BMJ Case Reports.

19 Jul 2021

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

A new study published in Vaccine assesses the safety and efficacy of the synthetic DNA vaccine candidate INO-4800, delivered as a single or double dose regime.

18 Jul 2021

Antihypertension drug may benefit patients with neurofibromatosis type 2

New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.

15 Jul 2021

High individual-level variability in SARS-CoV-2 shedding may explain superspreading

Researchers in the United States have provided a high-resolution description of the viral dynamics involved in acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

14 Jul 2021

Nose drops of modified 'friendly' bacteria offer protection against meningitis

A world-first trial has shown that nose drops of modified 'friendly' bacteria protect against meningitis.

12 Jul 2021

Fecal transplant and fiber supplementation can benefit patients with obesity-related metabolic syndrome

A transplant of healthy gut microbes followed by fiber supplements benefits patients with severe obesity and metabolic syndrome, according to University of Alberta clinical trial findings published today in Nature Medicine.

6 Jul 2021

Structure-guided T cell vaccine design could offer broad protection SARS-CoV-2 variants

Gaurav Gaiha, MD, DPhil, a member of the Ragon Institute of MGH, MIT and Harvard, studies HIV, one of the fastest-mutating viruses known to humankind.

2 Jul 2021

Researchers repurpose existing drugs to reduce severity of sleep apnea by at least 30%

New research published in The Journal of Physiology shows that researchers have successfully repurposed two existing medications to reduce the severity of sleep apnea in people by at least 30 per cent.

2 Jul 2021

Repurposing existing medications to reduce the severity of sleep apnea

In an Australian world-first, researchers have successfully repurposed two existing medications to reduce the severity of sleep apnea in people by at least 30 per cent.

2 Jul 2021

Expanding covid-19 symptom list could help improve the UK’s pandemic response

The UK should expand its official list of symptoms for defining covid-19 to prevent cases being missed and help improve the UK’s pandemic response, say experts in The BMJ today.

2 Jul 2021

Smell loss patients are being failed by healthcare professionals, study reveals

People who have lost their sense of smell are being failed by healthcare professionals, new research has revealed.

1 Jul 2021

How one rural town without a pharmacy is crowdsourcing to get meds

The building that once housed the last drugstore in this town of fewer than 600 is now a barbecue restaurant, where pit boss Larry Holtman dishes out smoked brisket and pulled pork across the same counter where pharmacists dispensed vital medications more than 30 years ago.

1 Jul 2021

Innovative corona test offers great potential for systematic testing

A new corona test developed at the University Hospital Bonn can analyze a large number of swabs simultaneously using sequencing technology and has a similarly high sensitivity as the common qPCR test.

29 Jun 2021

Covid-19 patients experience a longer lasting reduced sense of taste and smell

Patients with mild Covid-19 infections experience a significantly increased longer lasting reduced sense of taste and smell.

29 Jun 2021

SARS-CoV-2 test in 20 minutes with FISH

A collaboration from the University of Oxford and the University of Warwick has led to research into a novel method of viral detection through rapid fluorescence in situ hybridization (FISH) in order to effectively detect the SARS-CoV-2 virus within 20 minutes.

29 Jun 2021

New artificial intelligence system could lead to improved ways to control high ozone problems

Ozone levels in the earth's troposphere (the lowest level of our atmosphere) can now be forecasted with accuracy up to two weeks in advance, a remarkable improvement over current systems that can accurately predict ozone levels only three days ahead.

25 Jun 2021

Throat News and Research

Blunted antiviral responses in the nasopharynx may underlie severe COVID-19

Virginia Tech's in-house development of novel SARS-CoV-2 test shows the power of academic labs

Human coronaviruses need organic materials to transfer efficiently between surfaces

Study finds dramatic decreases in antibiotic dispensing for children during the pandemic

Patient's case report reveals link between Bell’s palsy and Pfizer-BioNTech vaccine

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

Antihypertension drug may benefit patients with neurofibromatosis type 2

High individual-level variability in SARS-CoV-2 shedding may explain superspreading

Nose drops of modified 'friendly' bacteria offer protection against meningitis

Fecal transplant and fiber supplementation can benefit patients with obesity-related metabolic syndrome

Structure-guided T cell vaccine design could offer broad protection SARS-CoV-2 variants

Researchers repurpose existing drugs to reduce severity of sleep apnea by at least 30%

Repurposing existing medications to reduce the severity of sleep apnea

Expanding covid-19 symptom list could help improve the UK’s pandemic response

Smell loss patients are being failed by healthcare professionals, study reveals

How one rural town without a pharmacy is crowdsourcing to get meds

Innovative corona test offers great potential for systematic testing

Covid-19 patients experience a longer lasting reduced sense of taste and smell

SARS-CoV-2 test in 20 minutes with FISH

New artificial intelligence system could lead to improved ways to control high ozone problems

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News